Suppression of established experimental autoimmune uveitis by anti-LFA-1α Ab

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 6, 2007, Pages 2667-2675

  Ke, Yan ^a   Sun, Deming ^a   Zhang, Ping ^a   Jiang, Guomin ^a   Kaplan, Henry J ^a   Shao, Hui ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1ALPHA AB ANTIBODY; UNCLASSIFIED DRUG; EYE PROTEIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MONOCLONAL ANTIBODY; RETINOL BINDING PROTEIN; RETINOL-BINDING GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; AUTOIMMUNE DISEASE; CELL INTERACTION; CELL MIGRATION; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; HISTOLOGY; IMMUNOREACTIVITY; INFLAMMATION; INFLAMMATORY CELL; MOUSE; NONHUMAN; PHOTORECEPTOR; PRIORITY JOURNAL; PROTEIN BINDING; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UVEITIS; ADOPTIVE TRANSFER; ANIMAL; C57BL MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHEMICALLY INDUCED DISORDER; COCULTURE; CYTOLOGY; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GERMFREE ANIMAL; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, MONOCLONAL; ASTROCYTES; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COCULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE PROTEINS; FEMALE; FLOW CYTOMETRY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MICE; MICE, INBRED C57BL; RETINOL-BINDING PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECIFIC PATHOGEN-FREE ORGANISMS; UVEITIS;

EID: 34347251966     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-1383     Document Type: Article

References (55)

1. Mochizuki M, Kuwabara T, McAllister C, Nussenblatt RB, Gery I. Adoptive transfer of experimental autoimmune uveoretinitis in rats: immunopathogenic mechanisms and histologic features. Invest Ophthalmol Vis Sci. 1985;26:1-9.
2. Gregerson DS, Obritsch WF, Fling SP, Cameron JD. S-antigen-specific rat T cell lines recognize peptide fragments of S-antigen and mediate experimental autoimmune uveoretinitis and pinealitis. J Immunol. 1986;136:2875-2882.
3. Shao H, Shi H, Kaplan HJ, Sun D. Chronic recurrent autoimmune uveitis with progressive photoreceptor damage induced in rats by transfer of IRBP-specific T cells. J Neuroimmunol. 2005;163:102-109.
4. Caspi RR. Immunogenetic aspects of clinical and experimental uveitis. Reg Immunol. 1992;4:321-330.
5. Shao H, Liao T, Ke Y, Shi H, Kaplan HJ, Sun D. Severe chronic experimental autoimmune uveitis (EAU) of the C57BL/6 mouse induced by adoptive transfer of IRBP1-20-specific T cells. Exp Eye Res. 2006;82:323-331.
6. Dubey C, Croft M, Swain SL. Costimulatory requirements of naive CD4+ T cells. ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response. J Immunol. 1995;155:45-57.
7. Riley JL, June CH. The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation. Blood. 2005;105:13-21.
8. Adorini L. Immunotherapeutic approaches in multiple sclerosis. J Neurol Sci. 2004;223:13-24.
9. Liossis SN, Sfikakis PP. Costimulation blockade in the treatment of rheumatic diseases. Biodrugs. 2004;18:95-102.
10. Pollard KM, Arnush M, Hultman P, Kono DH. Costimulation requirements of induced murine systemic autoimmune disease. J Immunol. 2004;173:5880-5887.
11. Stuart RW, Racke MK. Targeting T cell costimulation in autoimmune disease. Expert Opin Ther Targets. 2002;6:275-289.
12. Shao H, Fu Y, Liao T, et al. Anti-CD137 mAb treatment inhibits experimental autoimmune uveitis by limiting expansion and increasing apoptotic death of uveitogenic T cells. Invest Ophthalmol Vis Sci. 2005;46:596-603.
13. Shao H, Fu Y, Song L, Sun S, Kaplan HJ, Sun D. Lymphotoxin beta receptor-Ig fusion protein treatment blocks actively induced, but not adoptively transferred, uveitis in Lewis rats. Eur J Immunol. 2003;33:1736-1743.
14. Shao H, Woon MD, Nakamura S, et al. Requirement of B7-mediated costimulation in the induction of experimental autoimmune anterior uveitis. Invest Ophthalmol Vis Sci. 2001;42:2016-2021.
15. Zhang P, Sun D, Ke Y, Kaplan HJ, Shao H. The net effect of costimulatory blockers is dependent on the subset and activation status of the autoreactive T cells. J Immunol. 2007;178:474-479.
16. Kurzinger K, Reynolds T, Germain RN, Davignon D, Martz E, Springer TA. A novel lymphocyte function-associated antigen (LFA-1): cellular distribution, quantitative expression, and structure. J Immunol. 1981;127:596-602.
17. Davignon D, Martz E, Reynolds T, Kurzinger K, Springer TA. Monoclonal antibody to a novel lymphocyte function-associated antigen (LFA-1): mechanism of blockade of T lymphocyte-mediated killing and effects on other T and B lymphocyte functions. J Immunol. 1981;127:590-595.
18. Davignon D, Martz E, Reynolds T, Kurzinger K, Springer TA. Lymphocyte function-associated antigen 1 (LFA-1): a surface antigen distinct from Lyt-2,3 that participates in T lymphocyte-mediated killing. Proc Natl Acad Sci USA. 1981;78:4535-4539.
19. Nicolls MR, Gill RG. LFA-1 (CD11a) as a therapeutic target. Am J Transplant. 2006;6:27-36.
20. Grakoui A, Bromley SK, Sumen C, et al. The immunological synapse: a molecular machine controlling T cell activation. Science. 1999;285:221-227.
21. Lee KH, Holdorf AD, Dustin ML, Chan AC, Allen PM, Shaw AS. T cell receptor signaling precedes immunological synapse formation. Science. 2002;295:1539-1542.
22. Monks CRF, Freiberg BA, Kupfer H, Sciaky N, Kupfer A. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature. 1998;395:82-86.
23. Qi SY, Groves JT, Chakraborty AK. Synaptic pattern formation during cellular recognition. Proc Natl Acad Sci USA. 2001;98:6548-6553.
24. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994;76:301-314.
25. Bachmann MF, Kall-Faienza K, Schmits R, et al. Distinct Roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus costimulation. Immunity. 1997;7:549-557.
26. Kavanaugh AF, Lightfoot E, Lipsky PE, Oppenheimermarks N. Role of Cd11/Cd18 in adhesion and transendothelial migration of T-cells: analysis utilizing Cd18-deficient T-cell clones. J Immunol. 1991;146:4149-4156.
27. Hamann A, Jablonskiwestrich D, Duijvestijn A, et al. Evidence for an accessory role of Lfa-1 in lymphocyte-high endothelium interaction during homing. J Immunol. 1988;140:693-699.
28. Warnock RA, Askari S, Butcher EC, Andrian UH. Molecular mechanisms of lymphocyte homing to peripheral lymph nodes. J Exp Med. 1998;187:205-216.
29. Guerette B, Skuk D, Celestin F, et al. Prevention by anti-LFA-1 of acute myoblast death following transplantation. J Immunol. 1997;159:2522-2531.
30. Anderson ME, Siahaan TJ. Targeting ICAM-1/LFA-1 interaction for controlling autoimmune diseases: designing peptide and small molecule inhibitors. Peptides. 2003;24:487-501.
31. Bertry-Coussot L, Lucas B, Danel C, et al. Long-term reversal of established autoimmunity upon transient blockade of the LFA1/intercellular adhesion molecule-1 pathway. J Immunol. 2002;168:3641-3648.
32. Bruner RJ, Farag SS. Monoclonal antibodies for the prevention and treatment of graft-versus-host disease. Semin Oncol. 2003;30:509-519.
33. Calhoun RF, Oppat WF, Duffy B, Mohanakumar T. Intercellular adhesion molecule-1/leukocyte function associated antigen-1 blockade inhibits alloantigen specific human T cell effector functions without inducing anergy. Transplantation. 1999;68:1144-1152.
34. Connolly MK, Kitchens EA, Chan B, Jardieu P, Wofsy D. Treatment of murine lupus with monoclonal antibodies to lymphocyte function-associated antigen-1: dose-dependent inhibition of autoantibody production and blockade of the immune response to therapy. Clin Immunol Immunopathol. 1994;72:198-203.
35. Hasegawa Y, Yokono K, Taki T, et al. Prevention of autoimmune insulin-dependent diabetes in non-obese diabetic mice by anti-LFA-1 and anti-ICAM-1 mAb. Int Immunol. 1994;6:831-838.
36. Kevil CG, Hicks MJ, He X, et al. Loss of LFA-1, but not Mac-1, protects MRL/MpJ-Fas(lpr) mice from autoimmune disease. Am J Pathol. 2004;165:609-616.
37. Yusuf-Makagiansar H, Anderson ME, Yakovleva TV, Murray JS, Siahaan TJ. Inhibition of LFA-1/LCAM-1 and VLA-4/VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases. Med Res Rev. 2002;22:146-167.
38. Ando K, Fujino Y, Mochizuki M. Effects of monoclonal antibodies directed at cell surface molecules on murine experimental autoimmune uveoretinitis. Graefes Arch Clin Exp Ophthalmol. 1999;237:848-854.
39. Uchio E, Kijima M, Tanaka S, Ohno S. Suppression of experimental uveitis with monoclonal antibodies to ICAM-1 and LFA-1. Invest Ophthalmol Vis Sci. 1994;35:2626-2631.
40. Whitcup SM, DeBarge LR, Caspi RR, Harning R, Nussenblatt RB, Chan CC. Monoclonal antibodies against ICAM-1 (CD54) and LFA-1 (CD11a/CD18) inhibit experimental autoimmune uveitis. Clin Immunol Immunopathol. 1993;67:143-150.
41. Liao T, Ke Y, Shao WH, et al. Blockade of the interaction of leukotriene b4 with its receptor prevents development of autoimmune uveitis. Invest Ophthalmol Vis Sci. 2006;47:1543-1549.
42. Shao H, Peng Y, Liao T, et al. A shared epitope of the interphotoreceptor retinoid-binding protein recognized by the CD4+ and CD8+ autoreactive T cells. J Immunol. 2005;175:1851-1857.
43. Shao H, Lei S, Sun SL, Xiang J, Kaplan HJ, Sun D. CpG-containing oligodeoxynucleotide 1826 converts the weak uveitogenic rat interphotoreceptor retinoid-binding protein peptide 1181-1191 into a strong uveitogen. J Immunol. 2003;171:4780-4785.
44. Shao H, Sun SL, Kaplan HJ, Sun D. Characterization of rat CD8+ uveitogenic T cells specific for interphotoreceptor retinal-binding protein 1177-1191. J Immunol. 2004;173:2849-2854.
45. Forrester JV, Liversidge J, Dua HS. Regulation of the local immune response by retinal cells. Curr Eye Res. 1990;9(suppl)183-191.
46. Kim MC, Kabeer NH, Tandhasetti MT, Kaplan HJ, Bora NS. Immunohistochemical studies on melanin associated antigen (MAA) induced experimental autoimmune anterior uveitis (EAAU). Curr Eye Res. 1995;14:703-710.
47. Sun D, Le J, Yang S, Malotkey M, Coleclough C. Major role of antigen-presenting cells in the response of rat encephalitogenic T cells to myelin basic proteins. J Immunol. 1993;151:111-118.
48. Caspi RR. Immune mechanisms in uveitis. Springer Semin Immunopathol. 1999;21:113-124.
49. Dullforce PA, Seitz GW, Garman KL, et al. Antigen-specific accumulation of naive, memory and effector CD4 T cells during anterior uveitis monitored by intravital microscopy. Cell Immunol. 2006;239:49-60.
50. Peng Y, Shao H, Ke Y, et al. In vitro activation of CD8 interphotoreceptor retinoid-binding protein-specific T cells requires not only antigenic stimulation but also exogenous growth factors. J Immunol. 2006;176:5006-5014.
51. Hogg N, Smith A, McDowall A, et al. How T cells use LFA-1 to attach and migrate. Immunol Lett. 2004;92:51-54.
52. Xu H, Manivannan A, Jiang HR, et al. Recruitment of IFN-gamma-producing (Th1-like) cells into the inflamed retina in vivo is preferentially regulated by P-selectin glycoprotein ligand 1:P/E-selectin interactions. J Immunol. 2004;172:3215-3224.
53. Go S, Fleischmann A, Lantz O, et al. Anti-LFA-1 antibody postpones T-cell receptor triggering while preserving generation of regulatory T cells in T-cell receptor anti-HY transgenic mice. Transplantation. 2006;82:119-126.
54. Lunsford KE, Koester MA, Eiring AM, Horne PH, Gao D, Bumgardner GL. Targeting LFA-1 and CD154 suppresses the in vivo activation and development of cytolytic (CD4-independent) CD8+ T cells. J Immunol. 2005;175:7855-7866.
55. Pietrzak A, Podhorecka M, Chodorowska G, Rolinski J, Urban J. Efaluzimab in the treatment of psoriasis. Ann Univ Mariae Curie Sklodowska [Med]. 2003;58:174-178.